Skip to Content
Full Title A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node
Protocol Number MSLT-II
clinicaltrials.gov https://clinicaltrials.gov/show/NCT00389571
Principal Investigator(s) Heather B Neuman, MD, MS, FACS
Division General Surgery
Status Active, not recruiting
Description

Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed for 10 years.

Other Clinical Trials in the Department of Surgery
webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System